Filing Details

Accession Number:
0001576280-21-000017
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-12 20:19:29
Reporting Period:
2021-02-10
Accepted Time:
2021-02-12 20:19:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH Services-Medical Laboratories (8071) 454139254
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753159 Amirali Talasaz 505 Penobscot Drive
Redwood City CA 94063
Chairman, President And Coo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-10 4,069 $156.11 1,981,908 No 4 S Direct
Common Stock Disposition 2021-02-10 4,579 $156.77 1,977,329 No 4 S Direct
Common Stock Disposition 2021-02-10 709 $158.13 1,976,620 No 4 S Direct
Common Stock Disposition 2021-02-10 5,007 $158.97 1,971,613 No 4 S Direct
Common Stock Disposition 2021-02-10 4,583 $160.08 1,967,030 No 4 S Direct
Common Stock Disposition 2021-02-10 4,594 $161.06 1,962,436 No 4 S Direct
Common Stock Disposition 2021-02-10 27,471 $162.10 1,934,965 No 4 S Direct
Common Stock Disposition 2021-02-10 2,292 $162.88 1,932,673 No 4 S Direct
Common Stock Disposition 2021-02-10 5,000 $163.98 1,927,673 No 4 S Direct
Common Stock Disposition 2021-02-10 492 $156.11 509,139 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 701 $156.80 508,438 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 141 $158.08 508,297 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 759 $158.98 507,538 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 621 $160.07 506,917 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 653 $161.02 506,264 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 4,497 $162.11 501,767 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 496 $163.03 501,271 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-10 329 $163.94 500,942 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-11 2,308 $162.65 1,925,365 No 4 S Direct
Common Stock Disposition 2021-02-11 1,372 $164.10 1,923,993 No 4 S Direct
Common Stock Disposition 2021-02-11 48,728 $165.55 1,875,265 No 4 S Direct
Common Stock Disposition 2021-02-11 44,676 $166.51 1,830,589 No 4 S Direct
Common Stock Disposition 2021-02-11 49,899 $167.47 1,780,690 No 4 S Direct
Common Stock Disposition 2021-02-11 50,245 $168.37 1,730,445 No 4 S Direct
Common Stock Disposition 2021-02-11 5,023 $169.03 1,725,422 No 4 S Direct
Common Stock Disposition 2021-02-11 144 $162.81 500,798 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-11 204 $164.10 500,594 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-11 7,116 $165.55 493,478 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-11 6,764 $166.53 486,714 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Common Stock Disposition 2021-02-11 9,301 $167.47 477,413 No 4 S Indirect Shares held by Talasaz Investments, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
No 4 S Indirect Shares held by Talasaz Investments, L.P.
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.44 to $156.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The amount of shares beneficially owned reflects the addition of 345 shares that were previously incorrectly reported as sold on Form 4s filed on February 3, 2021 and February 5, 2021.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.44 to $157.255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.44 to $158.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.53 to $159.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.53 to $160.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.53 to $161.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.59 to $162.565, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.59 to $163.565, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  11. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.59 to $164.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  12. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $162.40 to $163.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  13. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.61 to $164.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  14. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.72 to $165.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  15. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.7275 to $166.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  16. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.74 to $167.735, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  17. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.74 to $168.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  18. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.74 to $169.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.